Regeneron Pharmaceuticals (REGN) Stock Insights
REGN$813.27-2.83 -0.35%
$83.73B
Market Cap
19.29
P/E
13.58
Forward P/E
55
Score
Regeneron Pharmaceuticals (REGN) Stock Insights
REGN price $813.27 -2.83 -0.35%
- Ticker
- REGN
- Price
- $813.27
- Change
- -2.83 -0.35%
- Market cap ?
- $83.73B
- P/E ?
- 19.29
- Forward P/E ?
- 13.58
- Dividend yield ?
- 0.46%
- Beta ?
- 0.24
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 55
- Value
- 53
- Quality
- 66
- Growth
- 46
Stocklytics score rationale: value 53, quality 66, growth 46.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 4860427000 | 5872227000 | 6710800000 | 6557600000 | 8497100000 | 16071700000 | 12172900000 | 13117200000 | 14202000000 | 14342900000 |
Regeneron Pharmaceuticals, Inc. is a global biopharmaceutical enterprise focused on discovering, inventing, developing, manufacturing, and bringing to market medical treatments for a wide array of illnesses. Its therapeutic portfolio includes EYLEA, an injection used to treat various ophthalmic conditions such as wet age-related macular degeneration, diabetic macular edema, myopic choroidal neovascularization…
Fair value
REGN fair value $1,370.05. Price $813.27. Price is 41% below fair value.
Below fair value, but more expensive than usual. A smaller discount than on 83% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 3.52B. Growth 6.25%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 102.95M. Net debt -412.20M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-10-30 | — | 16.36 | — | 4.56B |
| 2026-07-30 | 14.29 | 10.16 | 4.29B | 3.82B |
| 2026-04-29 | 9.47 | 8.91 | 3.61B | 3.48B |
| 2026-01-30 | 11.44 | 10.74 | 3.88B | 3.81B |
| 2025-10-28 | 11.83 | 9.65 | 3.75B | 3.59B |
| 2025-08-01 | 12.89 | 8.43 | 3.68B | 3.29B |
| 2025-04-29 | 8.22 | 8.62 | 3.03B | 3.25B |
| 2025-02-04 | 12.07 | 11.21 | 3.79B | 3.74B |
| 2024-10-31 | 12.46 | 11.69 | 3.72B | 3.67B |
| 2024-08-01 | 11.56 | 10.61 | 3.55B | 3.38B |
| 2024-05-02 | 9.55 | 10.17 | 3.15B | 3.23B |
| 2024-02-02 | 11.86 | 10.73 | 3.43B | 3.29B |
| 2023-11-02 | 11.59 | 10.72 | 3.36B | 3.22B |
| 2023-08-03 | 10.24 | 9.84 | 3.16B | 3.02B |
| 2023-05-04 | 10.09 | 9.25 | 3.16B | 3.00B |
| 2023-02-03 | 12.56 | 10.03 | 3.41B | 3.12B |
| 2022-11-03 | 11.14 | 9.48 | 2.94B | 2.92B |
| 2022-08-03 | 9.77 | 8.53 | 2.86B | 2.79B |
| 2022-05-04 | 8.93 | 9.74 | 2.97B | 2.69B |
| 2022-02-04 | 21.32 | 18.35 | 4.95B | 4.56B |
| 2021-11-04 | 14.37 | 10.10 | 3.45B | 2.69B |
| 2021-08-05 | 25.80 | 17.53 | 5.14B | 3.92B |
| 2021-05-06 | 9.89 | 9.00 | 2.53B | 2.65B |
| 2021-02-05 | 9.53 | 8.39 | 2.42B | 2.46B |
| 2020-11-05 | 8.36 | 7.14 | 2.29B | 301.49M |
| 2020-08-05 | 7.16 | 5.98 | 1.95B | 1.63B |
| 2020-05-05 | 6.60 | 6.13 | 1.83B | 1.70B |
| 2020-02-06 | 7.50 | 6.91 | 2.17B | 2.00B |
| 2019-11-05 | 6.67 | 6.36 | 2.05B | 1.95B |
| 2019-08-06 | 6.02 | 5.42 | 1.93B | 1.42B |
| 2019-05-07 | 4.45 | 5.47 | 1.71B | 1.69B |
| 2019-02-06 | 6.84 | 5.60 | 1.93B | 1.58B |
| 2018-11-06 | 5.87 | 5.13 | 1.66B | 1.45B |
| 2018-08-02 | 5.45 | 4.70 | 1.61B | 1.39B |
| 2018-05-03 | 4.67 | 4.35 | 1.51B | 1.41B |
| 2018-02-08 | 5.23 | 4.68 | 1.58B | 1.37B |
| 2017-11-08 | 3.99 | 3.85 | 1.50B | 1.45B |
| 2017-08-03 | 4.17 | 3.17 | 1.47B | 1.12B |
| 2017-05-04 | 2.92 | 3.06 | 1.32B | 1.38B |
| 2017-02-09 | 3.04 | 3.03 | 1.23B | 1.22B |
Dividends
Yield 0.45%. Payout ratio 8.74%. Frequency Quarterly.
Safety score 72/100 · Moderate. Payout ratio is 9% of earnings. Dividends use less than 40% of free cash flow. Dividend history is short. Yield is 0.5%, which is modest.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| 2026-08-18 | $0.94 | 2026-08-18 | 2026-08-31 | Quarterly |
| 2026-05-20 | $0.94 | 2026-05-20 | 2026-06-04 | Quarterly |
| 2026-02-20 | $0.94 | 2026-02-20 | 2026-03-05 | Quarterly |
| 2025-11-20 | $0.88 | 2025-11-20 | 2025-12-05 | Quarterly |
| 2025-08-18 | $0.88 | 2025-08-18 | 2025-09-03 | Quarterly |
| 2025-05-20 | $0.88 | 2025-05-20 | 2025-06-06 | Quarterly |
| 2025-02-20 | $0.88 | 2025-02-20 | 2025-03-20 | Quarterly |
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-14 | MURPHY ANDREW J | Sell | 6 | $753.76 | 4.52K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 35 | $755.91 | 26.46K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 16 | $757.68 | 12.12K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 24 | $758.16 | 18.20K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 14 | $759.96 | 10.64K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 74 | $760.65 | 56.29K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 27 | $761.36 | 20.56K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 55 | $762.57 | 41.94K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 25 | $763.76 | 19.09K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 219 | $764.40 | 167.40K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 271 | $765.39 | 207.42K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 279 | $766.47 | 213.85K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 192 | $767.39 | 147.34K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 105 | $768.33 | 80.67K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 127 | $769.30 | 97.70K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 12 | $770.20 | 9.24K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 283 | $771.56 | 218.35K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 211 | $772.56 | 163.01K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 224 | $773.40 | 173.24K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 121 | $774.48 | 93.71K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 376 | $775.46 | 291.57K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 66 | $776.31 | 51.24K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 38 | $777.76 | 29.55K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 454 | $778.64 | 353.50K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 380 | $779.59 | 296.24K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 463 | $780.63 | 361.43K |
| 2026-10-14 | MURPHY ANDREW J | Sell | 50 | $781.47 | 39.07K |
| 2026-10-13 | MURPHY ANDREW J | Buy | 17.00K | $381.92 | 6.49M |
| 2026-10-13 | MURPHY ANDREW J | Sell | 12.85K | $754.58 | 9.70M |
| 2026-10-13 | MURPHY ANDREW J | Sell | 17.00K | $381.92 | 6.49M |
| 2026-09-03 | McCourt Marion | Sell | 1.13K | $857.39 | 969.71K |
| 2026-09-02 | McCourt Marion | Sell | 1.22K | $850.00 | 1.03M |
| 2026-09-02 | Guarini Kathryn | Sell | 400 | $719.37 | 287.75K |
| 2026-09-02 | Guarini Kathryn | Buy | 400 | $719.37 | 287.75K |
| 2026-09-02 | Guarini Kathryn | Sell | 400 | $850.00 | 340.00K |
| 2026-08-19 | LAROSA JOSEPH J | Buy | 12.28K | $381.92 | 4.69M |
| 2026-08-19 | LAROSA JOSEPH J | Sell | 9.02K | $830.15 | 7.49M |
| 2026-08-19 | LAROSA JOSEPH J | Sell | 12.28K | $381.92 | 4.69M |
| 2026-08-18 | Fenimore Christopher R. | Buy | 6.28K | $381.92 | 2.40M |
| 2026-08-18 | Fenimore Christopher R. | Sell | 4.60K | $813.47 | 3.74M |
| 2026-08-18 | Fenimore Christopher R. | Sell | 6.28K | $381.92 | 2.40M |
| 2026-08-10 | Guarini Kathryn | Sell | 400 | $719.37 | 287.75K |
| 2026-08-10 | Guarini Kathryn | Buy | 400 | $719.37 | 287.75K |
| 2026-08-10 | Guarini Kathryn | Sell | 400 | $800.00 | 320.00K |
| 2026-08-10 | Zoghbi Huda Y | Buy | 800 | $376.69 | 301.35K |
| 2026-08-10 | Zoghbi Huda Y | Sell | 800 | $800.00 | 640.00K |
| 2026-08-10 | Zoghbi Huda Y | Sell | 800 | $376.69 | 301.35K |
| 2026-07-02 | RYAN ARTHUR F | Sell | 200 | $650.15 | 130.03K |
| 2026-05-01 | RYAN ARTHUR F | Sell | 5 | $701.76 | 3.51K |
| 2026-05-01 | RYAN ARTHUR F | Sell | 15 | $702.46 | 10.54K |
| 2026-05-01 | RYAN ARTHUR F | Sell | 24 | $703.46 | 16.88K |
| 2026-05-01 | RYAN ARTHUR F | Sell | 15 | $704.28 | 10.56K |
| 2026-05-01 | RYAN ARTHUR F | Sell | 14 | $705.56 | 9.88K |
| 2026-05-01 | RYAN ARTHUR F | Sell | 7 | $706.74 | 4.95K |
| 2026-05-01 | RYAN ARTHUR F | Sell | 4 | $707.40 | 2.83K |
| 2026-05-01 | RYAN ARTHUR F | Sell | 6 | $709.45 | 4.26K |
| 2026-05-01 | RYAN ARTHUR F | Sell | 2 | $710.87 | 1.42K |
| 2026-05-01 | RYAN ARTHUR F | Sell | 5 | $711.49 | 3.56K |
| 2026-05-01 | RYAN ARTHUR F | Sell | 1 | $712.09 | 712 |
| 2026-05-01 | RYAN ARTHUR F | Sell | 2 | $714.13 | 1.43K |
| 2026-04-01 | RYAN ARTHUR F | Sell | 1 | $771.32 | 771 |
| 2026-04-01 | RYAN ARTHUR F | Sell | 3 | $772.76 | 2.32K |
| 2026-04-01 | RYAN ARTHUR F | Sell | 8 | $773.59 | 6.19K |
| 2026-04-01 | RYAN ARTHUR F | Sell | 8 | $774.58 | 6.20K |
| 2026-04-01 | RYAN ARTHUR F | Sell | 14 | $775.58 | 10.86K |
| 2026-04-01 | RYAN ARTHUR F | Sell | 13 | $776.62 | 10.10K |
| 2026-04-01 | RYAN ARTHUR F | Sell | 9 | $777.42 | 7.00K |
| 2026-04-01 | RYAN ARTHUR F | Sell | 4 | $778.24 | 3.11K |
| 2026-04-01 | RYAN ARTHUR F | Sell | 40 | $779.71 | 31.19K |
| 2026-03-02 | RYAN ARTHUR F | Sell | 7 | $777.46 | 5.44K |
| 2026-03-02 | RYAN ARTHUR F | Sell | 2 | $778.30 | 1.56K |
| 2026-03-02 | RYAN ARTHUR F | Sell | 5 | $779.69 | 3.90K |
| 2026-03-02 | RYAN ARTHUR F | Sell | 3 | $780.69 | 2.34K |
| 2026-03-02 | RYAN ARTHUR F | Sell | 2 | $781.21 | 1.56K |
| 2026-03-02 | RYAN ARTHUR F | Sell | 2 | $782.62 | 1.57K |
| 2026-03-02 | RYAN ARTHUR F | Sell | 10 | $783.62 | 7.84K |
| 2026-03-02 | RYAN ARTHUR F | Sell | 9 | $784.48 | 7.06K |
| 2026-03-02 | RYAN ARTHUR F | Sell | 11 | $785.48 | 8.64K |
| 2026-03-02 | RYAN ARTHUR F | Sell | 7 | $786.61 | 5.51K |
| 2026-03-02 | RYAN ARTHUR F | Sell | 2 | $787.34 | 1.57K |
| 2026-03-02 | RYAN ARTHUR F | Sell | 20 | $788.96 | 15.78K |
| 2026-03-02 | RYAN ARTHUR F | Sell | 20 | $789.28 | 15.79K |
| 2026-02-19 | Zoghbi Huda Y | Buy | 1.64K | $376.69 | 617.02K |
| 2026-02-19 | Zoghbi Huda Y | Sell | 49 | $774.68 | 37.96K |
| 2026-02-19 | Zoghbi Huda Y | Sell | 50 | $775.50 | 38.77K |
| 2026-02-19 | Zoghbi Huda Y | Sell | 53 | $778.47 | 41.26K |
| 2026-02-19 | Zoghbi Huda Y | Sell | 208 | $779.55 | 162.15K |
| 2026-02-19 | Zoghbi Huda Y | Sell | 331 | $780.45 | 258.33K |
| 2026-02-19 | Zoghbi Huda Y | Sell | 209 | $781.28 | 163.29K |
| 2026-02-19 | Zoghbi Huda Y | Sell | 298 | $782.10 | 233.07K |
| 2026-02-19 | Zoghbi Huda Y | Sell | 220 | $783.29 | 172.32K |
| 2026-02-19 | Zoghbi Huda Y | Sell | 160 | $784.45 | 125.51K |
| 2026-02-19 | Zoghbi Huda Y | Sell | 56 | $785.61 | 43.99K |
| 2026-02-19 | Zoghbi Huda Y | Sell | 4 | $790.00 | 3.16K |
| 2026-02-19 | Zoghbi Huda Y | Sell | 1.64K | $376.69 | 617.02K |
| 2026-02-09 | Pitofsky Jason | Buy | 1.00K | $492.00 | 492.00K |
| 2026-02-09 | Pitofsky Jason | Sell | 20 | $775.95 | 15.52K |
| 2026-02-09 | Pitofsky Jason | Sell | 521 | $776.43 | 404.52K |
| 2026-02-09 | Pitofsky Jason | Sell | 391 | $777.51 | 304.01K |
| 2026-02-09 | Pitofsky Jason | Sell | 563 | $778.35 | 438.21K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 1.40K, holders -67 vs prior quarter. Ownership 89.28%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 9.11M | 165.77K | +1.85% | 5.68B |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.63M | -25.15K | -0.38% | 4.13B |
| DODGE & COX | 4.87M | 412.90K | +9.26% | 3.04B |
| STATE STREET CORP | 4.83M | 170.21K | +3.65% | 3.01B |
| INVESCO LTD. | 3.94M | 1.76M | +80.71% | 2.46B |
| JPMORGAN CHASE & CO | 3.77M | -537.61K | -12.47% | 2.38B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.18M | 1.45M | +84.53% | 1.98B |
| FRANKLIN TEMPLETON INC | 2.77M | 49.77K | +1.83% | 1.73B |
| GEODE CAPITAL MANAGEMENT, LLC | 2.63M | 18.08K | +0.69% | 1.63B |
| NUVEEN, LLC | 2.02M | -45.09K | -2.18% | 1.26B |
| LOOMIS SAYLES & CO L P | 1.86M | -53.14K | -2.78% | 1.16B |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.53M | -647.82K | -29.75% | 953.84M |
| MORGAN STANLEY | 1.40M | 78.38K | +5.94% | 871.53M |
| BANK OF AMERICA CORP /DE/ | 1.29M | 101.47K | +8.53% | 805.02M |
| WELLINGTON MANAGEMENT GROUP LLP | 1.27M | -567.37K | -30.88% | 791.95M |
| NORGES BANK | 1.17M | 1.17M | New | 731.29M |
| GOLDMAN SACHS GROUP INC | 1.16M | 975.59K | +520.04% | 725.30M |
| AQR CAPITAL MANAGEMENT LLC | 1.13M | -104.93K | -8.52% | 702.16M |
| AMUNDI | 1.01M | 3.74K | +0.37% | 631.98M |
| NORTHERN TRUST CORP | 916.47K | -25.47K | -2.70% | 571.45M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 846.31K | 846.31K | New | 527.71M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 846.31K | 41.80K | +5.20% | 527.71M |
| FMR LLC | 831.96K | -686.23K | -45.20% | 518.76M |
| CAPITAL WORLD INVESTORS | 814.92K | -604.08K | -42.57% | 508.14M |
| LEGAL & GENERAL GROUP PLC | 759.97K | 27.92K | +3.81% | 473.87M |
Insights
- Revenue by product
- Revenue by region
| Period | Value |
|---|---|
| FY2012 | Arcalyst Net Product Sales: 20200000.0, EYLEA Net Product Sales: 837900000.0 |
| FY2013 | Aflibercept Agreement: -15489000.0, Antibody Collaboration: 445600000.0 |
| FY2014 | Aflibercept Agreement: 5193000.0, Antibody Collaboration: 536106000.0 |
| FY2015 | Aflibercept Agreement: 15922000.0, Antibody Collaboration: 662990000.0, Immuno-oncology Agreement: 79961000.0, IO Agreement: 640000000.0 |
| FY2016 | Aflibercept Agreement: 26200000.0, Antibody Collaboration: 440168000.0, Immuno-oncology Agreement: 218497000.0, IO Agreement: 640000000.0 |
| FY2017 | Aflibercept Agreement: 24800000.0, Antibody Collaboration: 553689000.0, Immuno-oncology Agreement: 323504000.0 |
| FY2018 | Product: 4106200000.0 |
| FY2019 | Product: 4834400000.0 |
| FY2020 | Product: 5567600000.0 |
| FY2021 | Product: 12117200000.0, Product and Service, Other: 281200000.0 |
| FY2022 | Collaboration Revenue: 2058400000.0, Product: 6893700000.0, Product and Service, Other: 365100000.0 |
| FY2023 | Collaboration Revenue: 5503100000.0, Product: 7078000000.0, Product and Service, Other: 536100000.0 |
| FY2024 | Collaboration Revenue: 6057800000.0, Product: 7629200000.0, Product and Service, Other: 515000000.0 |
| FY2025 | Collaboration Revenue: 7331200000.0, Product: 6309100000.0, Product and Service, Other: 702600000.0 |
| Period | Value |
|---|---|
| FY2025 | Rest Of World: 507500000.0, UNITED STATES: 4384700000.0 |
Insights · Dividends · Forecast · Financials · Learn